InBody Co.,Ltd (KOSDAQ:041830)

South Korea flag South Korea · Delayed Price · Currency is KRW
26,950
-2,200 (-7.55%)
Oct 30, 2025, 3:30 PM KST
-7.55%
Market Cap328.58B
Revenue (ttm)217.55B
Net Income (ttm)30.62B
Shares Out12.19M
EPS (ttm)2,409.58
PE Ratio11.18
Forward PE9.99
Dividend400.00 (1.37%)
Ex-Dividend DateMar 28, 2025
Volume1,661,904
Average Volume78,819
Open32,650
Previous Close29,150
Day's Range26,550 - 32,650
52-Week Range20,700 - 32,650
Beta0.51
RSI41.12
Earnings DateNov 11, 2025

About InBody Co.,Ltd

InBody Co.,Ltd provides body composition analysis solutions worldwide. It offers body composition analyzers, automatic blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 1996
Employees 342
Stock Exchange KOSDAQ
Ticker Symbol 041830
Full Company Profile

Financial Performance

In 2024, InBody Co.,Ltd's revenue was 204.46 billion, an increase of 20.03% compared to the previous year's 170.35 billion. Earnings were 33.14 billion, a decrease of -9.75%.

Financial Statements

News

There is no news available yet.